Skip to Main Content

Paper Details

Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP).
Cancer Prev Res (Phila)
11
2021
Author NameAffiliation
Powel H BrownThe University of Texas MD Anderson Cancer Center
Eduardo VilarThe University of Texas MD Anderson Cancer Center
  • 1 - 2

Datasets

Release 1.2